THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 35 filers reported holding THERAVANCE INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $1,306,000 | +1.2% | 1,290,000 | -2.6% | 0.49% | -3.2% |
Q2 2018 | $1,291,000 | -13.5% | 1,325,000 | -4.7% | 0.50% | -14.7% |
Q1 2018 | $1,492,000 | +6.1% | 1,390,000 | -1.4% | 0.59% | +13.6% |
Q4 2017 | $1,406,000 | +131.6% | 1,410,000 | +125.6% | 0.52% | +139.0% |
Q3 2017 | $607,000 | – | 625,000 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kamunting Street Capital Management, L.P. | 13,872,000 | $10,378,000 | 36.43% |
GLG LLC | 28,210,000 | $21,510,000 | 1.28% |
Castle Creek Arbitrage, LLC | 17,110,000 | $12,950,000 | 0.99% |
Ferox Capital Management LP | 4,500,000 | $3,481,000 | 0.91% |
Baupost Group | 48,230,000 | $36,052,000 | 0.65% |
WOLVERINE ASSET MANAGEMENT LLC | 32,891,000 | $24,938,000 | 0.54% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 86,000,000 | $64,338,000 | 0.50% |
Man Investments (CH) AG | 500,000 | $381,000 | 0.15% |
ADVENT CAPITAL MANAGEMENT /DE/ | 11,327,000 | $8,710,000 | 0.13% |
PALISADE CAPITAL MANAGEMENT, LP | 2,299,000 | $1,731,000 | 0.06% |